Heat Shock Protein Inspired Nanochaperones Restore Amyloid-β Homeostasis for Preventative Therapy of Alzheimer’s Disease

The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics

Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864 · see citing works

Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy

Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359 · see citing works

Molecular chaperones in protein folding and proteostasis

Hartl, F. U., Bracher, A., & Hayer-Hartl, M. K. (2011) · Nature · doi:10.1038/nature10317 · Cited by 3,525 · see citing works

Molecular Chaperones in the Cytosol: from Nascent Chain to Folded Protein

Hartl, F. U., & Hayer-Hartl, M. K. (2002) · Science · doi:10.1126/science.1068408 · Cited by 3,335 · see citing works

Pathways towards and Away from Alzheimer’s Disease

Mattson, M. P. (2004) · Nature · doi:10.1038/nature02621 · Cited by 3,052 · see citing works

Phase 3 Trials of Solanezumab for Mild-to-Moderate Alzheimer's Disease

Doody, R. S., Thomas, R. G., Farlow, M., Iwatsubo, T., Vellas, B., Joffe, S., Kieburtz, K., Raman, R., Sun, X., Aisen, P. S., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1312889 · Cited by 1,668 · see citing works

Molecular Chaperone Functions in Protein Folding and Proteostasis

Kim, Y., Hipp, M. S., Bracher, A., Hayer-Hartl, M. K., & Hartl, F. U. (2013) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-060208-092442 · Cited by 1,468 · see citing works

Microglial Dysfunction and Defective β-Amyloid Clearance Pathways in Aging Alzheimer's Disease Mice

Hickman, S. E., Allison, E. K., & El Khoury, J. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.0616-08.2008 · Cited by 1,329 · see citing works

A Phase 3 Trial of Semagacestat for Treatment of Alzheimer's Disease

Doody, R. S., Raman, R., Farlow, M., Iwatsubo, T., Vellas, B., Joffe, S., Kieburtz, K., He, F., Sun, X., Thomas, R. G., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1210951 · Cited by 1,224 · see citing works

Mammalian stress response: cell physiology, structure/function of stress proteins, and implications for medicine and disease

Welch, W. J. (1992) · Physiological Reviews · doi:10.1152/physrev.1992.72.4.1063 · Cited by 1,190 · see citing works

Posttranslational Quality Control: Folding, Refolding, and Degrading Proteins

Wickner, S., Maurizi, M. R., & Gottesman, S. (1999) · Science · doi:10.1126/science.286.5446.1888 · Cited by 1,071 · see citing works

Modulation of neurodegeneration by molecular chaperones

Muchowski, P. J., & Wacker, J. L. (2004) · Nature reviews. Neuroscience · doi:10.1038/nrn1587 · Cited by 1,021 · see citing works

Multimodal techniques for diagnosis and prognosis of Alzheimer's disease

Perrin, R. J., Fagan, A. M., & Holtzman, D. M. (2009) · Nature · doi:10.1038/nature08538 · Cited by 702 · see citing works

Spontaneous assembly of subnanometre-ordered domains in the ligand shell of monolayer-protected nanoparticles

Jackson, A. M., Myerson, J. W., & Stellacci, F. (2004) · Nature Materials · doi:10.1038/nmat1116 · Cited by 570 · see citing works

Cellular and biochemical events in mammalian cells during and after recovery from physiological stress.

Welch, W. J., & Suhan, J. P. (1986) · The Journal of Cell Biology · doi:10.1083/jcb.103.5.2035 · Cited by 512 · see citing works

Heat Shock Proteins 70 and 90 Inhibit Early Stages of Amyloid β-(1–42) Aggregation in Vitro

Evans, C. G., Wisén, S., & Gestwicki, J. E. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m606192200 · Cited by 387 · see citing works

Misfolded proteins in Alzheimer's disease and type II diabetes

DeToma, A. S., Salamekh, S., Ramamoorthy, A., & Lim, M. H. (2011) · Chemical Society Reviews · doi:10.1039/c1cs15112f · Cited by 359 · see citing works

Immunology and immunotherapy of Alzheimer's disease

Weiner, H. L., & Frenkel, D. (2006) · Nature Reviews Immunology · doi:10.1038/nri1843 · Cited by 335 · see citing works

Microglial activation and amyloid‐β clearance induced by exogenous heat‐shock proteins

Kakimura, J., Kitamura, Y., Takata, K., Umeki, M., Suzuki, S., Shibagaki, K., Taniguchi, T., Nomura, Y., Gebicke‐Haerter, P. J., Smith, M. A., et al. (2002) · The FASEB Journal · doi:10.1096/fj.01-0530fje · Cited by 331 · see citing works

Transition-metal-substituted polyoxometalate derivatives as functional anti-amyloid agents for Alzheimer’s disease

Gao, N., Sun, H., Dong, K., Ren, J., Duan, T., Xu, C., & Qu, X. (2014) · Nature Communications · doi:10.1038/ncomms4422 · Cited by 263 · see citing works

Rationally Designed Peptides and Peptidomimetics as Inhibitors of Amyloid-β (Aβ) Aggregation: Potential Therapeutics of Alzheimer’s Disease

Goyal, D., Shuaib, S., Mann, S., & Goyal, B. (2017) · ACS Combinatorial Science · doi:10.1021/acscombsci.6b00116 · Cited by 229 · see citing works

Platinum-based inhibitors of amyloid-β as therapeutic agents for Alzheimer's disease

Barnham, K. J., Kenche, V. B., Ciccotosto, G. D., Smith, D. P., Tew, D. J., Liu, X., Perez, K. A., Cranston, G. A., Johanssen, T., Volitakis, I., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0800712105 · Cited by 210 · see citing works

Lysosomes, a meeting point of proteins, chaperones, and proteases

Cuervo, A. M., & Dice, J. F. (1997) · Journal of Molecular Medicine · doi:10.1007/s001090050185 · Cited by 202 · see citing works

Inhibition of Aggregation of Amyloid Peptides by Beta-Sheet Breaker Peptides and Their Binding Affinity

Man, V. H., Ngô, S. T., Lam, N. S., & Li, M. S. (2011) · The Journal of Physical Chemistry B · doi:10.1021/jp1116728 · Cited by 193 · see citing works

A Self-Destructive Nanosweeper That Captures and Clears Amyloid β-Peptides

Luo, Q., Lin, Y.-X., Yang, P.-P., Wang, Y., Qi, G.-B., Qiao, Z.-Y., Li, B.-N., Zhang, K., Zhang, J.-P., Wang, L., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04255-z · Cited by 191 · see citing works

PEGylated Nanoparticles Bind to and Alter Amyloid-Beta Peptide Conformation: Toward Engineering of Functional Nanomedicines for Alzheimer’s Disease

Brambilla, D., Verpillot, R., Droumaguet, B. L., Nicolas, J., Taverna, M., Kóňa, J., Lettiero, B., Hashemi, S. H., Kimpe, L. D., Canovi, M., et al. (2012) · ACS Nano · doi:10.1021/nn300489k · Cited by 188 · see citing works

Interaction of the Molecular Chaperone DNAJB6 with Growing Amyloid-beta 42 (Aβ42) Aggregates Leads to Sub-stoichiometric Inhibition of Amyloid Formation

Månsson, C., Arosio, P., Hussein, R. M., Kampinga, H. H., Hashem, R. M., Boelens, W. C., Dobson, C. M., Knowles, T. P. J., Linse, S. S., & Emanuelsson, C. S. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.595124 · Cited by 180 · see citing works

Maintenance of Amyloid β Peptide Homeostasis by Artificial Chaperones Based on Mixed‐Shell Polymeric Micelles

Huang, F., Wang, J., Qu, A., Shen, L., Liu, J., Liu, J., Zhang, Z., An, Y., & Shi, L. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201400735 · Cited by 152 · see citing works

Precise and Long-Term Tracking of Adipose-Derived Stem Cells and Their Regenerative Capacity via Superb Bright and Stable Organic Nanodots

Ding, D., Mao, D., Li, K., Wang, X., Qin, W., Liu, R., Chiam, D. S., Tomczak, N., Yang, Z., Tang, B. Z., et al. (2014) · ACS Nano · doi:10.1021/nn505554y · Cited by 144 · see citing works

Random Copolymer Films with Molecular‐Scale Compositional Heterogeneities that Interfere with Protein Adsorption

Baxamusa, S. H., & Gleason, K. K. (2009) · Advanced Functional Materials · doi:10.1002/adfm.200900943 · Cited by 129 · see citing works

Multiresponse Strategies To Modulate Burst Degradation and Release from Nanoparticles

Sankaranarayanan, J., Mahmoud, E., Kim, G., Morachis, J. M., & Almutairi, A. (2010) · ACS Nano · doi:10.1021/nn100968e · Cited by 118 · see citing works

Affinity-Based Inhibition of β-Amyloid Toxicity

Cairo, C. W., Strzelec, A., Murphy, R. M., & Kiessling, L. L. (2002) · Biochemistry · doi:10.1021/bi0156254 · Cited by 113 · see citing works

Architecture of the Alzheimer?s A�P Ion Channel Pore

Arispe, N. J. (2004) · The Journal of Membrane Biology · doi:10.1007/s00232-003-0638-7 · Cited by 111 · see citing works

Oligomer-specific Aβ toxicity in cell models is mediated by selective uptake

Chafekar, S. M., Baas, F., & Scheper, W. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2008.06.003 · Cited by 110 · see citing works

Molecular chaperones and neuronal proteostasis

Smith, H., Li, W., & Cheetham, M. E. (2015) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2015.03.003 · Cited by 107 · see citing works

Molecular mechanism of polyethylene glycol mediated stabilization of protein

Rawat, S., Suri, C. R., & Sahoo, D. K. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.01.067 · Cited by 94 · see citing works

Single Molecule Characterization of the Interactions between Amyloid-β Peptides and the Membranes of Hippocampal Cells

Narayan, P. S., Ganzinger, K. A., McColl, J. T., Weimann, L., Meehan, S., Qamar, S., Carver, J. A., Wilson, M. R., George‐Hyslop, P. S., Dobson, C. M., et al. (2013) · Journal of the American Chemical Society · doi:10.1021/ja3103567 · Cited by 82 · see citing works

Lessons from immunotherapy for Alzheimer disease

Wang, Y. (2014) · Nature Reviews Neurology · doi:10.1038/nrneurol.2014.44 · Cited by 77 · see citing works

Moving towards early clinical trials for amyloid-targeted therapy in Alzheimer's disease

Aisen, P. S. S., Vellas, B. J., & Hampel, H. J. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd3842-c1 · Cited by 76 · see citing works

In Vivo Biodistribution of Mixed Shell Micelles with Tunable Hydrophilic/Hydrophobic Surface

Gao, H., Xiong, J., Cheng, T., Liu, J., Chu, L., Liu, J., Ma, R., & Shi, L. (2013) · Biomacromolecules · doi:10.1021/bm301694t · Cited by 76 · see citing works

Stress proteins and glial functions: possible therapeutic targets for neurodegenerative disorders

Kitamura, Y., & Nomura, Y. (2002) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(02)00301-7 · Cited by 59 · see citing works

Neuroprotective Effect of Osthole on Neuron Synapses in an Alzheimer’s Disease Cell Model via Upregulation of MicroRNA-9

Li, S., Yan, Y., Jiao, Y., Gao, Z., Xia, Y., Kong, L., Yao, Y., Tao, Z., Song, J., Yan, Y., et al. (2016) · Journal of Molecular Neuroscience · doi:10.1007/s12031-016-0793-9 · Cited by 57 · see citing works

Synthetic Nanochaperones Facilitate Refolding of Denatured Proteins

Ma, F.-H., An, Y., Wang, J., Song, Y., Liu, Y., & Shi, L. (2017) · ACS Nano · doi:10.1021/acsnano.7b05947 · Cited by 55 · see citing works

Functionalized, Swellable Hydrogel Layers as a Platform for Cell Studies

Marí‐Buyé, N., O'Shaughnessy, S., Colominas, C., Semino, C. E., Gleason, K. K., & Borrós, S. (2009) · Advanced Functional Materials · doi:10.1002/adfm.200801561 · Cited by 54 · see citing works

Study on the Efficiency and Interaction Mechanism of a Decapeptide Inhibitor of β-Amyloid Aggregation

Liu, J., Wang, W., Zhang, Q., Zhang, S., & Yuan, Z. (2014) · Biomacromolecules · doi:10.1021/bm401795e · Cited by 54 · see citing works

BiP/GRP78-Induced Production of Cytokines and Uptake of Amyloid-β(1-42) Peptide in Microglia

Kakimura, J., Kitamura, Y., Taniguchi, T., Shimohama, S., & Gebicke‐Haerter, P. J. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.4299 · Cited by 48 · see citing works

Insights into the Stability of Native and Partially Folded States of Ubiquitin: Effects of Cosolvents and Denaturants on the Thermodynamics of Protein Folding

Jourdan, M., & Searle, M. S. (2001) · Biochemistry · doi:10.1021/bi010767j · Cited by 41 · see citing works

Vitamin D2 suppresses amyloid-β 25–35 induced microglial activation in BV2 cells by blocking the NF-κB inflammatory signaling pathway

Raha, S., Lee, H. J., Yumnam, S., Hong, G. E., Saralamma, V. V. G., Ha, Y. L., Kim, J. O., Kim, Y. S., Heo, J., Lee, S. J., et al. (2016) · Life Sciences · doi:10.1016/j.lfs.2016.07.017 · Cited by 39 · see citing works

Preparation of levodopa-loaded crystalsomes through thermally induced crystallization reverses functional deficits in Parkinsonian mice

Li, X., Liu, Q., Zhu, D., Che, Y., & Feng, X. (2019) · Biomaterials Science · doi:10.1039/c8bm01098f · Cited by 18 · see citing works

Advanced bioactive nanomaterials for biomedical applications

Zhao, Y., Zhang, Z., Pan, Z., & Liu, Y. (2021) · Exploration · doi:10.1002/exp.20210089 · Cited by 359 · see citing works

A review on advances of treatment modalities for Alzheimer's disease

Thoe, E. S., Fauzi, A., Tang, Y.-Q., Chamyuang, S., & Chia, A. Y. Y. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119129 · Cited by 224 · see citing works

Biomimetic Dendrimer–Peptide Conjugates for Early Multi‐Target Therapy of Alzheimer's Disease by Inflammatory Microenvironment Modulation

Liu, P., Zhang, T., Chen, Q., Li, C., Chu, Y., Guo, Q., Zhang, Y., Zhou, W., Chen, H., Zhou, Z., et al. (2021) · Advanced Materials · doi:10.1002/adma.202100746 · Cited by 137 · see citing works

Polymeric nanoparticle-based nanovaccines for cancer immunotherapy

Zhang, Y., Chen, J., Shi, L., & Ma, F. (2022) · Materials Horizons · doi:10.1039/d2mh01358d · Cited by 95 · see citing works

Reactive oxygen species-sensitive materials: A promising strategy for regulating inflammation and favoring tissue regeneration

Zhou, J., Fang, C., Rong, C., Luo, T., Liu, J., & Zhang, K. (2023) · Smart Materials in Medicine · doi:10.1016/j.smaim.2023.01.004 · Cited by 88 · see citing works

Mimetic Heat Shock Protein Mediated Immune Process to Enhance Cancer Immunotherapy

Li, X., Cai, X., Zhang, Z., Ding, Y., Ma, R., Huang, F., Liu, Y., Liu, J., & Shi, L. (2020) · Nano Letters · doi:10.1021/acs.nanolett.0c01230 · Cited by 77 · see citing works

Photoresponsive materials for intensified modulation of Alzheimer's amyloid-β protein aggregation: A review

Liu, W., Dong, X., Liu, Y., & Sun, Y. P. (2021) · Acta Biomaterialia · doi:10.1016/j.actbio.2021.01.018 · Cited by 74 · see citing works

Carbon nitride-based nanocaptor: An intelligent nanosystem with metal ions chelating effect for enhanced magnetic targeting phototherapy of Alzheimer's disease

Gong, L., Zhang, X., Ge, K., Yin, Y., Machuki, J. O., Yang, Y. Q., Shi, H., Geng, D., & Gao, F. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.120483 · Cited by 72 · see citing works

Graphene oxide improves postoperative cognitive dysfunction by maximally alleviating amyloid beta burden in mice

Zhang, J., Zhu, S., Jin, P., Huang, Y., Dai, Q., Zhu, Q., Wei, P., Yang, Z., Zhang, L., Liu, H., et al. (2020) · Theranostics · doi:10.7150/thno.50616 · Cited by 60 · see citing works

Tau-Targeted Multifunctional Nanoinhibitor for Alzheimer’s Disease

Zhu, L., Xu, L., Wu, X., Dèng, F., Ma, R., Liu, Y., Huang, F., & Shi, L. (2021) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.1c00257 · Cited by 59 · see citing works

Recent Advances in Therapeutics for the Treatment of Alzheimer’s Disease

Thawabteh, A. M., Ghanem, A. W., AbuMadi, S., Thaher, D., Jaghama, W., Karaman, D., & Karaman, R. (2024) · Molecules · doi:10.3390/molecules29215131 · Cited by 56 · see citing works

Ultrasensitive and Wearable Carbon Hybrid Fiber Devices as Robust Intelligent Sensors

Hu, Y., Huang, T., Zhang, H., Lin, H., Zhang, Y., Ke, L., Cao, W., Hu, K., Ding, Y., Wang, X., et al. (2021) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.1c03615 · Cited by 54 · see citing works

The application of nanotechnology in treatment of Alzheimer’s disease

Cao, Y., & Zhang, R. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.1042986 · Cited by 54 · see citing works

Coassembly of Macrocyclic Amphiphiles for Anti-β-Amyloid Therapy of Alzheimer’s Disease

Pan, Y., Wang, H., Xu, X., Tian, H., Zhao, H., Hu, X., Zhao, Y., Liu, Y., Ding, G., Meng, Q., et al. (2020) · CCS Chemistry · doi:10.31635/ccschem.020.202000561 · Cited by 51 · see citing works

The applications of nanozymes in neurological diseases: From mechanism to design

Zhang, Y., Zhang, L., Wang, M., & Li, P. (2023) · Theranostics · doi:10.7150/thno.83370 · Cited by 50 · see citing works

A diselenide bond-containing ROS-responsive ruthenium nanoplatform delivers nerve growth factor for Alzheimer's disease management by repairing and promoting neuron regeneration

Yuan, X., Jia, Z., Li, J., Liu, Y., Huang, Y., Gong, Y., Guo, X., Chen, X., Cen, J., & Liu, J. (2021) · Journal of Materials Chemistry B · doi:10.1039/d1tb01290h · Cited by 47 · see citing works

Brain-targeting drug delivery systems.

Liu, P.-X., & Jiang, C. (2022) · Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1818 · Cited by 40 · see citing works

Poly (β‐amino esters) based potential drug delivery and targeting polymer; an overview and perspectives (review)

Iqbal, S., Qu, Y., Dong, Z., Zhao, J., Khan, A. R., Rehman, S., & Zhao, Z. (2020) · European Polymer Journal · doi:10.1016/j.eurpolymj.2020.110097 · Cited by 45 · see citing works

Fabry disease: Mechanism and therapeutics strategies

Li, X., Ren, X., Zhang, Y., Ding, L., Huo, M., & Li, Q. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1025740 · Cited by 43 · see citing works

Dual-targeted carbon-dot-drugs nanoassemblies for modulating Alzheimer's related amyloid-β aggregation and inhibiting fungal infection

Yan, C., Wang, C., Shao, X., Shu, Q., Hu, X., Guan, P., Teng, Y., & Cheng, Y. (2021) · Materials Today Bio · doi:10.1016/j.mtbio.2021.100167 · Cited by 43 · see citing works

Composite of gold nanoclusters and basified human serum albumin significantly boosts the inhibition of Alzheimer's β-amyloid by photo-oxygenation

Liu, W., Zhang, H., Dong, X., & Sun, Y. P. (2022) · Acta Biomaterialia · doi:10.1016/j.actbio.2022.03.019 · Cited by 42 · see citing works

Insulin Delivery Using Dynamic Covalent Boronic Acid/Ester‐Controlled Release

Banach, Ł., Williams, G. T., & Fossey, J. (2021) · Advanced Therapeutics · doi:10.1002/adtp.202100118 · Cited by 41 · see citing works

Engineering a pathological tau-targeted nanochaperone for selective and synergetic inhibition of tau pathology in Alzheimer's Disease

Xu, L., Ding, Y., Ma, F., Chen, Y., Chen, G., Zhu, L., Long, J., Ma, R., Liu, Y., Liu, J., et al. (2022) · Nano Today · doi:10.1016/j.nantod.2022.101388 · Cited by 41 · see citing works

Engineering heterogeneity of precision nanoparticles for biomedical delivery and therapy

Zheng, D., Yang, K., & Nie, Z. (2021) · Open Research (University of Surrey) · doi:10.1002/viw.20200067 · Cited by 40 · see citing works

Nanochaperones Mediated Delivery of Insulin

Li, C., Liu, X., Zhang, Y., Lv, J., Huang, F., Wu, G., Liu, Y., Ma, R., An, Y., & Shi, L. (2020) · Nano Letters · doi:10.1021/acs.nanolett.9b04966 · Cited by 38 · see citing works

Stepwise Coordination-Driven Metal–Phenolic Nanoparticle as a Neuroprotection Enhancer for Alzheimer’s Disease Therapy

Yin, Z., Zhang, Z., Gao, D., Luo, G., Ma, T., Wang, Y., Lu, L., & Gao, X. (2022) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.2c18060 · Cited by 37 · see citing works

Suppression of a core metabolic enzyme dihydrolipoamide dehydrogenase (dld) protects against amyloid beta toxicity in C. elegans model of Alzheimer's disease

Ahmad, W., & Ebert, P. (2020) · Genes and Diseases · doi:10.1016/j.gendis.2020.08.004 · Cited by 30 · see citing works

Artificial Molecular Chaperone Systems for Proteins, Nucleic Acids, and Synthetic Molecules

Nishimura, T., & Akiyoshi, K. (2020) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.0c00133 · Cited by 36 · see citing works

Nanochaperone‐Based Strategies to Control Protein Aggregation Linked to Conformational Diseases

Caballero, A. B., & Gámez, P. (2020) · Angewandte Chemie International Edition · doi:10.1002/anie.202007924 · Cited by 35 · see citing works

Block copolymers in Alzheimer's disease therapy: A perceptive to revolutionize biomaterials

Revdekar, A., & Shende, P. K. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.11.007 · Cited by 33 · see citing works

Phototherapy via Modulation of β‐Amyloid in Combating Alzheimer's Disease

Zhang, Y., Qian, C., Chen, Y., He, W., & Guo, Z. (2025) · Aggregate · doi:10.1002/agt2.70020 · Cited by 31 · see citing works

Particle Nanoarchitectonics for Nanomedicine and Nanotherapeutic Drugs with Special Emphasis on Nasal Drugs and Aging

Aziz, T. A., Nadeem, A. A., Sarwar, A., Perveen, I., Hussain, N., Khan, A. A., Daudzai, Z., Cui, H., & Lin, L. (2023) · Biomedicines · doi:10.3390/biomedicines11020354 · Cited by 30 · see citing works

Pterostilbene participates in TLR4- mediated inflammatory response and autophagy-dependent Aβ1–42 endocytosis in Alzheimer's disease

Xu, J., Liu, J., Li, Q., Li, G., Zhang, G., Mi, Y., Zhao, T., Mu, D., Wang, D., Zeng, K., et al. (2023) · Phytomedicine · doi:10.1016/j.phymed.2023.155011 · Cited by 26 · see citing works

A Balance Between Capture and Release: How Nanochaperones Regulate Refolding of Thermally Denatured Proteins

Ma, F., Wu, X., Li, A., Xu, L., An, Y., & Shi, L. (2021) · Angewandte Chemie International Edition · doi:10.1002/anie.202101462 · Cited by 24 · see citing works

Tailoring a Nanochaperone to Regulate α‐Synuclein Assembly

Wu, X., Ma, F., Pan, B., Zhang, Y., Zhu, L., Dèng, F., Xu, L., Zhao, Y., Yin, X., Niu, H., et al. (2022) · Angewandte Chemie International Edition · doi:10.1002/anie.202200192 · Cited by 24 · see citing works

Nanomodulators That Target Alzheimer’s Disease: A Review

Pradhan, N., & Jana, N. R. (2024) · ACS Applied Nano Materials · doi:10.1021/acsanm.3c04846 · Cited by 22 · see citing works

Process-biomimetic macromolecular materials for in vivo applications

Gong, X.-F., Li, Y., Wang, D., Cao, H., Yang, Z., Wang, H., & Wang, L. (2022) · Progress in Materials Science · doi:10.1016/j.pmatsci.2022.101015 · Cited by 21 · see citing works

Programmable DNA Nanodevices for Applications in Neuroscience

Hivare, P., Panda, C., Gupta, S. K., & Bhatia, D. D. (2021) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.0c00723 · Cited by 21 · see citing works

Multifunctional mesoporous nanoselenium delivery of metformin breaks the vicious cycle of neuroinflammation and ROS, promotes microglia regulation and alleviates Alzheimer's disease

Guo, X., Zhang, B., Chen, Y., Zhi, J., Yuan, X., Zhang, L., Liu, J., & Liu, Y. (2024) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2024.114300 · Cited by 20 · see citing works

Rational Design of Nitrogen-Doped Carbon Dots for Inhibiting β-Amyloid Aggregation

Liu, H., Guo, H., Fang, Y., Wang, L. F., & Li, P. (2023) · Molecules · doi:10.3390/molecules28031451 · Cited by 18 · see citing works

Regulation of STING G-quadruplex for rescuing cellular senescence and Aβ phagocytic capacity of microglia

Yuan, H., Yang, J., Qin, G., Sun, Y., Zhao, C., Wang, C., Ren, J., & Qu, X. (2024) · Chemical Science · doi:10.1039/d4sc04453c · Cited by 17 · see citing works

Therapeutic Nanomaterials for Neurological Diseases and Cancer Therapy

Wang, K., Zhu, X., Yu, E., Desai, P. P., Wang, H., Zhang, C., Zhuge, Q., Yang, J., & Hu, J. (2020) · Journal of Nanomaterials · doi:10.1155/2020/2047379 · Cited by 17 · see citing works

The Potential of Edible and Medicinal Resource Polysaccharides for Prevention and Treatment of Neurodegenerative Diseases

Gan, Q., Ding, Y., Peng, M., Chen, L., Dong, J., Hu, J., & Ma, Y. (2023) · Biomolecules · doi:10.3390/biom13050873 · Cited by 16 · see citing works

Amyloid-β aggregates-restricted rotational motion amplifies photo-catalytic activity from quinolinium derivatives

Liu, H., Li, Y., Wei, L., Ye, Z., Yuan, J., & Xiao, L. (2024) · Nano Today · doi:10.1016/j.nantod.2024.102434 · Cited by 12 · see citing works

Self-Assembled Nanochaperones Inhibit the Aggregation of Human Islet Amyloid Polypeptide Associated with Type 2 Diabetes

Niu, H., Hou, X., Zhang, Y., Wu, X., Dèng, F., Huang, F., Shi, L., & Ma, R. (2021) · ACS Macro Letters · doi:10.1021/acsmacrolett.1c00200 · Cited by 16 · see citing works

Particulate systems for improving therapeutic efficacy of pharmaceuticals against central nervous system-related diseases

Kuo, Y., & Rajesh, R. (2020) · Journal of the Taiwan Institute of Chemical Engineers · doi:10.1016/j.jtice.2020.09.012 · Cited by 15 · see citing works

Advanced bioactive nanomaterials for diagnosis and treatment of major chronic diseases

Liu, Y., Yi, Y., Zhong, C., Ma, Z., Wang, H., Dong, X., Yu, F., Li, J., Chen, Q., Lin, C., et al. (2023) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2023.1121429 · Cited by 14 · see citing works

Cascade-targeting multifunctional nanochaperone remodels brain microenvironment for synergistic therapy of Alzheimer’s disease

Zhang, X., Hu, H., Li, Q., Zhao, Y., Zhang, Z., Zhao, S., Xu, L., Ma, R., Huang, F., & Shi, L. (2024) · Nano Today · doi:10.1016/j.nantod.2024.102168 · Cited by 14 · see citing works

Engineered Nanoparticle-Protein Interactions Influence Protein Structural Integrity and Biological Significance

Jaiswal, S., Manhas, A., Pandey, A. K., Priya, S., & Sharma, S. (2022) · Nanomaterials · doi:10.3390/nano12071214 · Cited by 14 · see citing works

The use of nanoparticles in the treatment of infectious diseases and cancer, dental applications and tissue regeneration: a review

Nasab, A. S., Banafshe, H. R., Atapour, A., Mahabady, M. K., Akbari, M., Daraei, A., Mansoori, Y., & Hasan‐Abad, A. M. (2024) · Frontiers in Medical Technology · doi:10.3389/fmedt.2023.1330007 · Cited by 13 · see citing works

Ratiometric Imaging of Mitochondrial Hydrogen Peroxide in Aβ42-Mediated Neurotoxicity

Li, X., Zhang, Y., & Ai, H. (2022) · ACS Sensors · doi:10.1021/acssensors.1c01381 · Cited by 12 · see citing works

Blood-brain barrier permeable carbon nano-assemblies for amyloid-β clearance and neurotoxic attenuation

Hou, T., Yang, Q., Ding, M., Wang, X., Mei, K., Guan, P., Wang, C., & Hu, X. (2024) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2024.114182 · Cited by 11 · see citing works

Clinical-grade human dental pulp stem cells improve adult hippocampal neural regeneration and cognitive deficits in Alzheimer's disease

Xiong, W., She, W., Liu, Y., Zhou, H., Wang, X., Fang, L., Li, R., Wang, J., Qin, D., Jing, S., et al. (2024) · Theranostics · doi:10.7150/thno.102315 · Cited by 11 · see citing works

Nanochaperone‐Based Strategies to Control Protein Aggregation Linked to Conformational Diseases

Caballero, A. B., & Gámez, P. (2020) · Angewandte Chemie · doi:10.1002/ange.202007924 · Cited by 11 · see citing works

Bidirectional Regulation of Intracellular Enzyme Activity Using Light‐Driven Nano‐Inhibitors

Zhao, Y., Huang, Q., Li, Q., Chen, Z., & Liu, Y. (2024) · Angewandte Chemie International Edition · doi:10.1002/anie.202318533 · Cited by 10 · see citing works

Nanoplatforms Targeting Intrinsically Disordered Protein Aggregation for Translational Neuroscience Applications

Lo, C. H., Cheong, L. Y. T., & Zeng, J. (2025) · Nanomaterials · doi:10.3390/nano15100704 · Cited by 10 · see citing works

Self-assembled nanochaperones enable the disaggregation of amyloid insulin fibrils

Wang, H., Li, A., Yang, M., Zhao, Y., Shi, L., & Ma, R. (2021) · Science China Chemistry · doi:10.1007/s11426-021-1155-9 · Cited by 10 · see citing works

Treatment of Alzheimer's disease by microcapsule regulates neurotransmitter release via microfluidic technology

Yao, W., Che, J., Zhao, C., Zhang, X., Zhou, H., & Bai, F. (2023) · Engineered Regeneration · doi:10.1016/j.engreg.2023.02.005 · Cited by 10 · see citing works

Gold Nanoclusters Enhance the Efficacy of the Polymer-Based Chaperone in Restoring and Maintaining the Native Conformation of Human Islet Amyloid Polypeptide

Zhou, L. P., Gao, G., Ma, Z., Zhang, Z., Gu, Z., Yu, L., Li, X., Zhang, N., Qian, L., Tao, Z., et al. (2023) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.2c17777 · Cited by 9 · see citing works

Development of nanomedicines for the treatment of Alzheimer’s disease: Raison d’être, strategies, challenges and regulatory aspects

Mazahir, F., Alam, M. I., & Yadav, A. K. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102318 · Cited by 9 · see citing works

Nano‐Chaperones: Bridging Therapeutics for Amyloid Aggregation in Alzheimer's Disease and Type‐2 Diabetes Mellitus

Siddiqui, F., Mishra, P., Khanam, S., Ranjan, S., Alam, P., Albalawi, T., Khan, S., & Mir, S. S. (2025) · European Journal of Neuroscience · doi:10.1111/ejn.70142 · Cited by 8 · see citing works

Advances in Alzheimer’s disease control approaches via carbon nanotubes

Cai, J., Li, B., Zhang, J., Feng, G., Liu, Y., Fan, H., & Zheng, B. (2024) · Nanomedicine · doi:10.1080/17435889.2024.2432855 · Cited by 7 · see citing works

Bioinspired Self-assembly Nanochaperone Inhibits Tau-Derived PHF6 Peptide Aggregation in Alzheimer’s Disease

Zhu, L., Zhang, M., Jing, H., Zhang, X.-P., Xu, L., Ma, R., Huang, F., & Shi, L. (2022) · Chinese Journal of Polymer Science · doi:10.1007/s10118-022-2799-9 · Cited by 7 · see citing works

Therapeutic nanosweepers promote β-amyloid removal from the brain for Alzheimer's disease treatment

Xu, H., Zhao, Y., Qi, Y., Xue, X., & Liu, Y. (2022) · Biomaterials Science · doi:10.1039/d2bm01319c · Cited by 7 · see citing works

Allosteric synthetic antibody (Allo-SyAb) for improved cancer immunotherapy

Chen, J., Xu, M., Zhang, Y., Xu, L., Zhao, S., An, Y., Ma, R., Liu, Y., Ma, F., & Shi, L. (2023) · Chemical Engineering Journal · doi:10.1016/j.cej.2023.142374 · Cited by 7 · see citing works

Nonintuitive Immunogenicity and Plasticity of Alpha-Synuclein Conformers: A Paradigm for Smart Delivery of Neuro-Immunotherapeutics

Abioye, A. O., Akintade, D. D., Mitchell, J., Olorode, S., & Adejare, A. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16050609 · Cited by 6 · see citing works

Functional nanochaperones for PEGylated insulin delivery in long-term glycemic control

Wu, X., Zhang, Y., Song, S., Liu, S., Ma, F., Ma, R., & Shi, L. (2024) · Biomaterials Science · doi:10.1039/d4bm01163e · Cited by 6 · see citing works

Nanoparticle-Based Imaging Techniques in Neurological Disorders

Thangaleela, S., Wang, C., Revathi, S., Sivamaruthi, B. S., & Chaiyasut, C. (2025) · Nanotechnology in the life sciences · doi:10.1007/978-3-031-80185-3_3 · Cited by 6 · see citing works

“Spear and shield in one” nanochaperone enables protein to navigate multiple biological barriers for enhanced tumor synergistic therapy

Zhang, X., Wang, D., Wu, X., Zhao, Y., Li, X., Ma, R., Huang, F., & Shi, L. (2022) · Biomaterials Science · doi:10.1039/d2bm00409g · Cited by 6 · see citing works

Nanochaperones tailored for insulin delivery to reduce immune clearance and enhance bioavailability of insulin

Zhang, Y., Li, C., Wu, X., Dèng, F., Huang, F., Zhang, Y., Liu, J., Gui, H., Ma, R., & Shi, L. (2022) · Chemical Engineering Journal · doi:10.1016/j.cej.2022.134866 · Cited by 6 · see citing works

Temperature-Responsive Self-Assembly Nanochaperone Protects Green Fluorescent Proteins from Thermal Denaturation

Zhao, S., Li, B., Song, Y., Wu, S., Hu, H., Wang, J., Shi, L., & Huang, F. (2024) · Supramolecular Materials · doi:10.1016/j.supmat.2024.100067 · Cited by 5 · see citing works

Chaperones as Potential Pharmacological Targets for Treating Protein Aggregation Illness

Rani, S., & Tuteja, M. (2025) · Current Protein and Peptide Science · doi:10.2174/0113892037338028241230092414 · Cited by 5 · see citing works

Effectiveness of epigallocatechin gallate nanoparticles on the in-vivo treatment of Alzheimer’s disease in a rat/mouse model: a systematic review

Khalifa, M. K. A., Abdel-Sattar, S. A., Amin, O. M., Kohaf, N. A., Zaky, H. S., El-Fattah, M. A. A., Mohammed, K. H. A., Badawi, N. M., Mansoor, I., & Eassa, H. A. (2023) · DARU Journal of Pharmaceutical Sciences · doi:10.1007/s40199-023-00494-8 · Cited by 5 · see citing works

Hierarchical adhesive hydrogel microparticles with galantamine hydrobromide encapsulation for the treatment of Alzheimer’s disease

Zhou, H., Yao, W., Shan, Q., Zhang, X., Zhang, D., Che, J., & Bai, F. (2024) · Materials & Design · doi:10.1016/j.matdes.2024.113322 · Cited by 5 · see citing works

Chimeric collagen-like proteins with tunable structural heterogeneity for precise control and targeted doxorubicin delivery

Xia, Y., Li, Y., Huang, J., Wang, L., Feng, J. Q., Li, J., Liu, C., Jia, S., Man, S., Li, S., et al. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.114131 · Cited by 4 · see citing works

A Balance Between Capture and Release: How Nanochaperones Regulate Refolding of Thermally Denatured Proteins

Ma, F., Wu, X., Li, A., Xu, L., An, Y., & Shi, L. (2021) · Angewandte Chemie · doi:10.1002/ange.202101462 · Cited by 3 · see citing works

Bidirectional Regulation of Intracellular Enzyme Activity Using Light‐Driven Nano‐Inhibitors

Zhao, Y., Huang, Q., Li, Q., Chen, Z., & Liu, Y. (2024) · Angewandte Chemie · doi:10.1002/ange.202318533 · Cited by 3 · see citing works

Application of nanomaterials in central nervous system disorders

Deng, Y., Feng, Y., Ye, B., Hu, L., Qi, L., Wang, C., Zhou, C., Liu, G., Gao, X., Lin, C., et al. (2025) · Psychopharmacology · doi:10.1007/s00213-025-06862-3 · Cited by 2 · see citing works

Fight Aβ Aggregation with Molecular Aggregates

Wang, C. H., Zhang, D., Hu, M., & Wang, X. (2025) · Macromolecular Chemistry and Physics · doi:10.1002/macp.202400531 · Cited by 2 · see citing works

A validated criterion for engineering 0D@2D nanocomposite to modulate amyloid peptide self-assembly and fibril disassembly

Mu, Q., Gao, G., Zhang, Z., Zhang, B., Gu, Z., Liu, X., Yu, L., Shen, L., & Sun, T. (2025) · Chemical Engineering Journal · doi:10.1016/j.cej.2025.160577 · Cited by 1 · see citing works

Breaking the Alzheimer’s Treatment Stalemate: Synergistic Application Strategies of Nanomaterials and Pharmaceutical Agents

Gao, H., Cheng, F., Zhang, Z., Yan, B., Liao, P., Zhang, S., Li, D., Chen, F., & Lei, P. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05320-7 · Cited by 1 · see citing works

Aβ-Targeted Theranostic Agent for NIR Fluorescence Imaging Guided Type-I and Type-II Dual Photodynamic Therapy of Alzheimer’s Disease

Liu, G., Xie, X., Niu, Y., Li, Y., Zhang, J., Jiao, X., Dou, X., Tang, Y., Wang, X., & Tang, B. (2026) · Analytical Chemistry · doi:10.1021/acs.analchem.5c07740 · Cited by 1 · see citing works

“Live” Nanomaterials Process Biomimetic Recognition and Assembly In Vivo

Zhang, K., Li, Y., Huang, B. S., Cao, H., Wang, L., & Wang, H. (2023) · Small Science · doi:10.1002/smsc.202300032 · Cited by 1 · see citing works

Significant downregulation of Alzheimer's amyloid-β levels enabled by engineered DNA nanomaterials

Sun, Y., Sun, J. W., Feng, Y., Zhang, Y., Li, J., Wang, F., Loznik, M., Tian, Y., Zhang, H., Herrmann, A. P., et al. (2024) · Fundamental Research · doi:10.1016/j.fmre.2024.03.017 · Cited by 1 · see citing works

Tailoring a Nanochaperone to Regulate α‐Synuclein Assembly

Wu, X., Ma, F., Pan, B., Zhang, Y., Zhu, L., Dèng, F., Xu, L., Zhao, Y., Yin, X., Niu, H., et al. (2022) · Angewandte Chemie · doi:10.1002/ange.202200192 · Cited by 1 · see citing works

Polymeric Nanotherapeutics for Alzheimer’s Disease: Summary and Outlook

Xu, L., Huang, F., & Shi, L. (2023) · Chinese Journal of Polymer Science · doi:10.1007/s10118-023-2949-8 · Cited by 1 · see citing works

A Comprehensive Review on the Newer Therapeutic Approaches in Treating Alzheimer’s Disease

Prakash, R., Jayaraman, R., Palei, N. N., Prakash, D. J., & Ronald, D. (2024) · Springer eBooks · doi:10.1007/978-981-19-3949-5_40-1

A Comprehensive Review on the Newer Therapeutic Approaches in Treating Alzheimer’s Disease

Prakash, R., Jayaraman, R., Palei, N. N., Prakash, D. J., & Ronald, D. (2024) · Springer eBooks · doi:10.1007/978-981-99-7557-0_40

Advances in Self‐Assembly Artificial Chaperone for Protein Folding Regulation

Zhao, S., Zong, X., Shi, L., & Huang, F. (2026) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.70059

PEGylated protein nanoparticles for the inhibition of Aβ fibrillation via Aβ binding with minimal nonspecific protein interactions

Waku, T., Yoshikawa, T., Okuda, M., Sugimoto, H., Matsuo, K., & Kobori, A. (2026) · Polymer Journal · doi:10.1038/s41428-026-01175-4

Bibliometric analysis of nanomaterials in the diagnosis and treatment of neurological and psychiatric disorders (1997–2025): trends and future directions

Luo, M. H., Zhao, F., Wang, Y.-M., Bian, J., & Luo, Y. (2026) · Journal of Nanobiotechnology · doi:10.1186/s12951-026-04529-5

Sequential targeting nanochaperone disrupts positive feedback loop of mitochondrial dysfunction for Alzheimer's disease therapy

Hu, H., Zhao, S., Xu, L., Ma, Z., Ma, R., Huang, F., & Shi, L. (2026) · Biomaterials · doi:10.1016/j.biomaterials.2026.124408

Integrated bioinformatics and experimental analysis identify apoptosis- and pyroptosis-related hub genes as candidate diagnostic biomarkers in Alzheimer’s disease

Cai, Y. P., Chen, Y., Huang, G., Ren, M., Chai, Y., Gai, C., Huang, X., & Yan, T. (2026) · Journal of Applied Genetics · doi:10.1007/s13353-026-01095-2

Restoring mitochondria and associated chaperone function: New therapeutic strategies for neurodegenerative diseases

Xia, X., Zhang, J., Lin, X., Zhao, X., Mao, C., Wu, Z., & Wan, M. (2026) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2026.109101

Nanomaterial Interventions in Pathological Biomolecular Phase Transitions of Neurodegeneration and Cancer

Wang, R., Wu, W., Jiang, X., & Bao, H. (2026) · Small · doi:10.1002/smll.75569

Cascade-targeting multifunctional nanochaperone remodels brain microenvironment for synergistic therapy of Alzheimer’s disease

Zhang, X., Hu, H., Li, Q., Zhao, Y., Zhang, Z., Zhao, S., Xu, L., Ma, R., Huang, F., & Shi, L. (2024) · Nano Today · doi:10.1016/j.nantod.2024.102168 · Cited by 14 · see citing works

Bioinspired Self-assembly Nanochaperone Inhibits Tau-Derived PHF6 Peptide Aggregation in Alzheimer’s Disease

Zhu, L., Zhang, M., Jing, H., Zhang, X.-P., Xu, L., Ma, R., Huang, F., & Shi, L. (2022) · Chinese Journal of Polymer Science · doi:10.1007/s10118-022-2799-9 · Cited by 7 · see citing works

Maintenance of Amyloid β Peptide Homeostasis by Artificial Chaperones Based on Mixed‐Shell Polymeric Micelles

Huang, F., Wang, J., Qu, A., Shen, L., Liu, J., Liu, J., Zhang, Z., An, Y., & Shi, L. (2014) · Angewandte Chemie · doi:10.1002/ange.201400735 · Cited by 16 · see citing works

Amino Acid–Driven Gold Nanochaperone Platforms for Alzheimer’s Therapy: A Mechanistic and Design Framework for Protein Misfolding Modulation

Siddiqui, F., Khanam, S., Faruqui, T., Mishra, P., Mahmood, S., Mir, S. S., & Khan, S. (2026) · Molecular Neurobiology · doi:10.1007/s12035-026-05955-0

Nanochaperones Based on Hydrophobic Interaction and Coordination Inhibit Protein Misfolding and Fibrillation

Wang, H., Xu, L., Shi, L., & Ma, R. (2024) · Chinese Journal of Polymer Science · doi:10.1007/s10118-024-3169-6 · Cited by 5 · see citing works